Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients
Sponsor
Canadian Breast Cancer Research Alliance (Other)
Overall Status
Unknown status
CT.gov ID
NCT00390169
Collaborator
British Columbia Cancer Agency (Other)
300
1
33
9.1
Study Details
Study Description
Brief Summary
This study will compare three standard treatment programs commonly offered to patients with breast cancer. The three programs being compared are 1) Mindfulness Meditation-Based Stress Reduction (MBSR), 2)Supportive- Expressive Group Therapy (SET), and 3) A one day stress-management seminar. The purpose of this study is to determine if these three treatments have different effects on psychological well-being, the immune system, and the amount of stress hormones in the bloodstream.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Randomized Controlled Trial Comparing Mindfulness-Based Stress Reduction (MBSR) to Supportive-Expressive Therapy (SET) on Psychological and Biological Outcomes in Breast Cancer Patients
Study Start Date
:
Oct 1, 2006
Study Completion Date
:
Jul 1, 2009
Outcome Measures
Primary Outcome Measures
- Psychological:mood, stress, post-traumatic growth, social support, quality of life, spirituality []
- Physical:cortisol levels (stress hormone) []
Secondary Outcome Measures
- emotional repression []
- personality []
- emotional suppression []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Study participants must be women diagnosed with Stage I, II, or III breast cancer within the previous 18 months, have completed all treatments with the exception of hormonal therapy at least three months previously, over the age of 18, and have a score of 13 or higher on the BSI-18. Previous meditation/yoga experience is allowed but will be recorded.
Exclusion Criteria:
- Participants must not have a concurrent DSM-IV diagnosis of psychosis, substance abuse, bipolar disorder, or active suicidality (as assessed by structured clinical interview), must not be currently using psychotropic medications (antipsychotics, antidepressants, anxiolytics), have a concurrent autoimmune disorder, or have participated previously in MBSR or SET group.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Tom Baker Cancer Centre | Calgary | Alberta | Canada | T2N 4N2 |
Sponsors and Collaborators
- Canadian Breast Cancer Research Alliance
- British Columbia Cancer Agency
Investigators
- Principal Investigator: Linda E Carlson, Ph.D, AHS Cancer Control Alberta
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
- Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12(4):278-85.
- Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology. 2004 May;29(4):448-74.
- Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom Med. 2003 Jul-Aug;65(4):571-81.
Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00390169
Other Study ID Numbers:
- 20444
- CBCRA #017728
First Posted:
Oct 19, 2006
Last Update Posted:
Jan 19, 2012
Last Verified:
Aug 1, 2011
Keywords provided by ,
,
Additional relevant MeSH terms: